Invention Grant
![[1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases](/docs/US/2022-08-09/US11407755B2/abs.jpg.600x600.jpg)
- Patent Title: [1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases
-
Application No.: US16930911Application Date: 2020-07-16
-
Publication No.: US11407755B2Publication Date: 2022-08-09
- Inventor: Robert Hugh Bradbury , Alfred Arthur Rabow , Michael James Waring , James Francis McCabe , Steven Christopher Glossop , Arshed Mahmood , Zoe Ann Cotter
- Applicant: AstraZeneca AB
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agency: McNeill Baur PLLC
- Main IPC: C07D487/04
- IPC: C07D487/04 ; E21B7/06
![[1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases](/abs-image/US/2022/08/09/US11407755B2/abs.jpg.150x150.jpg)
Abstract:
The invention concerns compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R1, R2 and n have any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use as anti-proliferative and/or cell-killing agents.
Public/Granted literature
- US20210107905A1 1,2,4]TRIAZOLO[4,3-B]PYRIDAZINES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES Public/Granted day:2021-04-15
Information query
